G
6.47
-0.45 (-6.50%)
| 前收盘价格 | 6.92 |
| 收盘价格 | 6.75 |
| 成交量 | 705,686 |
| 平均成交量 (3个月) | 1,602,038 |
| 市值 | 376,220,768 |
| 价格/销量 (P/S) | 1.59 |
| 股市价格/股市净资产 (P/B) | 0.570 |
| 52周波幅 | |
| 利润日期 | 6 May 2025 |
| 营业毛利率 | -240.94% |
| 营业利益率 (TTM) | -214.69% |
| 稀释每股收益 (EPS TTM) | -10.54 |
| 季度收入增长率 (YOY) | 26.20% |
| 总债务/股东权益 (D/E MRQ) | 65.32% |
| 流动比率 (MRQ) | 5.62 |
| 营业现金流 (OCF TTM) | -319.58 M |
| 杠杆自由现金流 (LFCF TTM) | -235.06 M |
| 资产报酬率 (ROA TTM) | -19.67% |
| 股东权益报酬率 (ROE TTM) | -60.34% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Ginkgo Bioworks Holdings, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-0.8
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.83 |
|
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 6.57% |
| 机构持股比例 | 81.26% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ecor1 Capital, Llc | 31 Dec 2024 | 1,743,344 |
| Opaleye Management Inc. | 31 Dec 2024 | 1,200,000 |
| Forbes J M & Co Llp | 31 Dec 2024 | 701,732 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合